ASTRAZENECA PLC
02723534Manufacture of basic pharmaceutical products
ASTRAZENECA PLC
Manufacture of basic pharmaceutical products
Previous Company Names
Contact & Details
Contact
Registered Address
1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AA United Kingdom
Full company profile for ASTRAZENECA PLC (02723534), an active life sciences and medical technology company based in Cambridge, United Kingdom. Incorporated 17 Jun 1992. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Balance Sheet & P&L (2013–2025)
Cash in Bank
£5741.00M
Net Assets
£48719.00M
Total Liabilities
£65355.00M
Turnover
£59120.00M
Employees
N/A
Debt Ratio
57%
Financial History
Revenue, profit, EBITDA and key financial figures
2025 31 Dec Year End | 2024 31 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
See all 6 grants
Sign up to view complete grant history
Investors (0)
No investor information available
Officers
Officers
| Status | |||||||
|---|---|---|---|---|---|---|---|
No officers found | |||||||
No officers found
See all 67 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (0)
No PSC information available
Group Structure
Group Structure
Charges
Charges
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 9 Jun 2026 | Capital | Allotment of shares (USD 387,751,080.25) on 13 May 2026 | |
| 27 May 2026 | Confirmation Statement | Confirmation statement made on 15 May 2026 with updates | |
| 19 May 2026 | Capital | Allotment of shares (GBP 50,000) on 22 Apr 2026 | |
| 1 May 2026 | Officers | Termination of Rene Anthony Andrada Haas as director on 30 Apr 2026 | |
| 30 Apr 2026 | Resolution | Resolutions |
Allotment of shares (USD 387,751,080.25) on 13 May 2026
Confirmation statement made on 15 May 2026 with updates
Allotment of shares (GBP 50,000) on 22 Apr 2026
Termination of Rene Anthony Andrada Haas as director on 30 Apr 2026
Resolutions
Recent Activity
Latest Activity
Allotment of shares (USD 387,751,080.25) on 13 May 2026
6 days ago on 9 Jun 2026
Confirmation statement made on 15 May 2026 with updates
2 weeks ago on 27 May 2026
Allotment of shares (GBP 50,000) on 22 Apr 2026
3 weeks ago on 19 May 2026
Termination of Rene Anthony Andrada Haas as director on 30 Apr 2026
1 months ago on 1 May 2026
Resolutions
1 months ago on 30 Apr 2026